Adjuvant Therapy of Melanoma With Sentinel Node Micrometastasis: Anti-PD-1 Render Superior RFS vs. Ipi, Dabrafenib / Trametinib in Stage 3 V600E/K BRAF Disease Have Survival Advantage
By
8th International Congress on Cancer Metastasis
FEATURING
Kevin Kim
By
8th International Congress on Cancer Metastasis
FEATURING
Kevin Kim
Login to view comments.
Click here to Login
Current Management of Melanoma Patients